Table 1 Patient characteristics, treatment modalities, clinical parameters and patient outcome
From: Hemoadsorption by CytoSorb in septic patients: a case series
Case number | Sex | Age | Source | APACHE II | Abx | CytoSorb treatments (n) | Delay (h) | Cat-free days | Details on renal outcome/recovery on ICU | CRRT (days) | Ventilation (days) | Hospital stay (days) | ICU stay (days) | Predicted mortality | 28-Day mortality | ICU mortality | Hospital mortality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 76 | Abd | 45 | Mero-Line-Cas | 5 | 24 | 0 | Non-recovery | 15 | 17 | 17 | 17 | 97.5 | Yes | Yes | Yes |
2 | M | 58 | Abd | 48 | Pip/T | 3 | 24 | 7 | Non-recovery | 16 | 51 | 51 | 50 | 98.4 | No | Yes | Yes |
3 | F | 35 | Abd | 27 | Pip/T-Clinda | 2 | 24 | 28 | Recovery | 3 | 36 | 43 | 41 | 73.7 | No | No | No |
4 | M | 41 | Abd | 39 | Mero-Fosfo | 3 | 24 | 25 | Recovery | 13 | 27 | 36 | 36 | 94.2 | No | No | No |
5 | F | 58 | Abd | 27 | Cefta-Levo | 2 | 24 | 1 | Non-recovery | 2 | 3 | 4 | 4 | 73.7 | Yes | Yes | Yes |
6 | M | 75 | Abd | 37 | Mero-Cas | 3 | 24 | 0 | Non-recovery | 4 | 4 | 11 | 4 | 92.3 | Yes | Yes | Yes |
7 | M | 65 | Abd | 45 | Mero | 1 | 24 | 15 | Non-recovery | 3 | 3 | 18 | 18 | 97.5 | Yes | Yes | Yes |
8 | M | 54 | Abd | 37 | Mero | 4 | 24 | 1 | Recovery | 6 | 19 | 20 | 20 | 92.3 | Yes | Yes | Yes |
9 | M | 56 | Abd | 29 | Pip/T-Clinda | 3 | 36 | 3 | Non-recovery | 5 | 16 | 15 | 15 | 78.9 | Yes | Yes | Yes |
10 | F | 51 | Abd | 32 | Levo-Cefta-Cas | 1 | 48 | 0 | Non-recovery | 1 | 10 | 10 | 10 | 85.3 | Yes | Yes | Yes |
11 | F | 49 | Abd | 29 | Mero-Line-Cas | 3 | 48 | 18 | Recovery | 3 | 27 | 138 | 33 | 78.9 | No | No | Yes |
12 | M | 63 | Abd | 48 | Cefta-Line-Cas | 1 | 96 | 6 | Non-recovery | 3 | 14 | 14 | 14 | 98.4 | Yes | Yes | Yes |
13 | M | 72 | Abd | 34 | Pip/T | 2 | 72 | 4 | Non-recovery | 3 | 4 | 14 | 5 | 88.6 | Yes | Yes | Yes |
14 | M | 74 | Pneu | 33 | Mero | 5 | 24 | 0 | Recovery | 14 | 28 | 40 | 40 | 87 | No | Yes | Yes |
15 | M | 65 | Pneu | 33 | Pip/T | 3 | 24 | 0 | Non-recovery | 3 | 4 | 6 | 6 | 87 | Yes | Yes | Yes |
16 | M | 64 | Pneu | 56 | Pip/T | 3 | 24 | 31 | Recovery | 11 | 37 | 40 | 40 | 99.5 | No | No | No |
17 | M | 17 | Pneu | 29 | Cefta-Clon | 2 | 24 | 0 | Unknown | 2 | 2 | 2 | 2 | 78.9 | No | No | No |
18 | F | 72 | Pneu | 40 | Pip/T-Ery | 1 | 24 | 0 | Non-recovery | 1 | 1 | 1 | 1 | 94.9 | Yes | Yes | Yes |
19 | M | 58 | Pneu | 27 | Pip/T-Ery | 2 | 48 | 13 | Chronic | 9 | 16 | 43 | 21 | 73.7 | Yes | Yes | Yes |
20 | F | 79 | Pneu | 27 | Pip/T-Ery-Cas | 3 | 48 | 30 | Recovery | 20 | 34 | 46 | 40 | 73.7 | No | No | No |
21 | M | 62 | Pneu | 33 | Mero-Line | 3 | 48 | 2 | Non-recovery | 14 | 18 | 20 | 20 | 87 | Yes | Yes | Yes |
22 | M | 62 | Pneu | 54 | Pip/T-Clinda | 3 | 48 | - | Recovery | 19 | 33 | 35 | 35 | 99.3 | No | Yes | Yes |
23 | F | 53 | Pneu | 33 | Pip/t-Ery | 2 | 36 | 1 | Non-recovery | 3 | 3 | 4 | 4 | 87 | Yes | Yes | Yes |
24 | M | 64 | Pneu | 36 | Mero | 3 | 120 | 47 | Recovery | 16 | 45 | 88 | 72 | 91.2 | No | No | Yes |
25 | M | 43 | Pneu | 52 | Pip/T-Ery-Cas | 2 | 120 | 0 | Chronic | 3 | 12 | 12 | 12 | 99.1 | Yes | Yes | Yes |
26 | M | 46 | Pneu | 44 | Pip/T | 3 | 50 | 0 | Non-recovery | 7 | 7 | 7 | 7 | 97.1 | Yes | Yes | Yes |